Cautions and warnings on the US OTC label for nicotine replacement: What's a doctor to do?

Addictive Behaviors

Volumn 36, Issue 4, 2011, Pages 327-332

  Zapawa, Lisa M ^a   Hughes, John R ^b   Benowitz, Neal L ^c   Rigotti, Nancy A ^d   Shiffman, Saul ^a,e  

^a PINNEY ASSOCIATES   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Nicotine replacement therapy; Smoking cessation; Substance use disorder; Tobacco use cessation; Tobacco use disorder

Indexed keywords

NICOTINE; NON PRESCRIPTION DRUG;

ADDICTION; ARTICLE; DRUG EFFICACY; DRUG LABELING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERNET; MEDLINE; NICOTINE REPLACEMENT THERAPY; PHYSICIAN; SMOKING CESSATION; TIME; TOBACCO;

CHEWING GUM; DRUG THERAPY, COMBINATION; HUMANS; NICOTINIC AGONISTS; NONPRESCRIPTION DRUGS; SELF MEDICATION; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79151484437     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2010.12.003     Document Type: Article

References (59)

1. American Psychiatric Association (APA) Diagnostic and statistical manual of mental disorders 2000, text revision, American Psychiatric Association, Washington, DC. 4th ed.
2. Bansal M.A., Cummings K.M., Hyland A., Giovino G.A. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them?. Nicotine and Tobacco Research 2004, 6(Suppl 3):S303-S310.
3. Batra A., Klingler K., Landfeldt B., Friederich H.M., Westin Å., Danielsson T. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study. Clin Pharmacol Ther 2005, 78:689-696.
4. Benowitz N.L. Summary: risks and benefits of nicotine. Nicotine Safety and Toxicity 1998, 185-194. Oxford University Press, New York. N.L. Benowitz (Ed.).
5. Benowitz N.L., Gourlay S.G. Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy. Journal of the American College of Cardiology 1997, 29:1422-1431.
6. Benowitz N.L., Zevin S., Jacob P. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. Journal of Pharmacology and Experimental Therapeutics 1998, 287(3):958-962.
7. Borland R. Slip-ups and relapse in attempts to quit smoking. Addictive Behaviors 1990, 15(3):235-245.
8. Bullen C., Howe C., Lin R.B., Grigg M., Laugesen M., McRobbie H., et al. Pre-cessation nicotine replacement therapy: Pragmatic randomized trial. Addiction 2010, 105(8):1474-1483.
9. Committee on Safety of Medicines and Healthcare Products Regulatory Agency (CSMHPRA) Report of the committee on safety of medicines working group on nicotine replacement therapy 2006 2006, CSM & MHRSA, London. http://www.mhra.gov.uk.
10. Croghan G.A., Sloan J.A., Croghan I.T., Novotny P., Hurt R.D., DeKrey W.L., et al. Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting. Nicotine & Tobacco Research 2003, 5:181-187.
11. electronic Medicines Compendium (eMC) Nicorette 2mg Gum SPC 2005, (Date of revision: 30 September 2005), [Accessed 2 April 2009 and available at:. http://emc.medicines.org.uk/searchresults.aspx?term=Nicorette+2mg+Gum&searchtype=QuickSearch.
12. Etter J.F., Huguelet P., Perneger T.V., Cornuz J. Nicotine gum treatment before smoking cessation: A randomized trial. Arch Intern Med 2009, 169:1028-1034.
13. Fagerström K.O. Can reduced smoking be a way for smokers not interested in quitting to actually quit?. Respiration 2005, 72(2):216-220.
14. Fagerström K.O., Hughes J.R. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: A review. Nicotine & Tobacco Research 2002, S73-S79.
15. Ferguson S.G., Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. Journal of Substance Abuse Treatment 2009, 36:235-243.
16. Ferry L.H., Grissino L.M., Runfola P.S. Tobacco dependence curricula in US undergraduate medical education. Journal of the American Medical Association 1999, 282(9):825-829.
17. Fiore M.C., Jaen C.R., Baker T.B., Bailey W.C., Benowitz N.L., Curry S.J., et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline 2008, May, U.S. Department of Health and Human Services, Rockville, MD, Public Health Service.
18. Gitchell J., Ferguson S., Shiffman S. Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Poster presented at the Annual Meeting of the Society for Research on Nicotine and Tobacco, Austin, Texas 2007, February.
19. Hammond D., Reid J.L., Driezen P., Cummings K.M., Borland R., Fong F.T., et al. Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: Findings from the ITC Four Country Survey. Addiction 2008, 103:1696-1703.
20. Hughes J.R. Long-term use of nicotine-replacement therapy. Conference Proceedings 1991, 63-70. J.E. Henningfield, M.L. Stitzer (Eds.).
21. Hughes J.R., Carpenter M.J. Does smoking reduction increase future cessation and decrease risk? A qualitative review. Nicotine & Tobacco Research 2006, 8:739-749.
22. Hughes J.R., Pillitteri J.L., Callas P.W., Callahan R., Kenny M. Misuse of and dependence on over-the-counter nicotine gum in a volunteer sample. Nicotine & Tobacco Research 2004, 6(1):79-84.
23. Humfleet G., Hall S.M., Sees K.L., Reus V., Munoz R., Hartz D. Brief versus extended smoking treatment: Preliminary findings. Presented at the Annual Meeting of The Society for Research on Nicotine and Tobacco, Seattle, Washington March 2001.
24. Hurt R.D., Offord K.P., Lauger G.G., Marusic Z., Fagerström K.O., Enright P.L., et al. Cessation of long-term nicotine gum use-A prospective, randomized trial. Addiction 1995, 90:407-413.
25. Johnson R.E., Stevens V.J., Hollis J.F., Woodson G.T. Nicotine chewing gum use in the outpatient care setting. Journal of Family Practice 1992, 34:61-65.
26. Joseph A.M., Norman S.M., Ferry L.H., Prochazka A.V., Westman E.C., Steele B.G., et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New England Journal of Medicine 1996, 335(24):1-15.
27. Kozlowski L.T., Giovino G.A., Edwards B., DiFranza J., Foulds J., Hurt R., et al. Advice on using over-the-counter nicotine replacement therapy-patch, gum, or lozenge-to quit smoking. Addictive Behaviors 2007, 32:2140-2150.
28. Mahmarian J.J., Moye L.A., Nasser G.A., Nagueh S.F., Bloom M.F., Benowitz N.L., et al. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. Journal of the American College of Cardiology 1997, 30(1):125-130.
29. McNeill A., Foulds J., Bates C. Regulation of nicotine replacement therapies (NRT): a critique of current practice. Addiction 2001, 96(12):1757-1768.
30. Medioni J., Berlin I., Mallet A. Increased risk of relapse after stopping nicotine replacement therapies: A mathematical modeling approach. Addiction 2005, 100:247-254.
31. Molyneux A. ABC of smoking cessation: nicotine replacement therapy. BMJ 2004, 328:454-456.
32. Murray R.P., Bailey W.C., Daniels K., Bjornson W.M., Kurnow K., Connett J.E., et al. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 1996, 109(2):438-445.
33. National Institute for Clinical Excellence (NICE) Smoking cessation-Bupropion and nicotine replacement therapy. NICE Technology Appraisal Guidance No. 39. London March, 2002, Accessed on 2 April 2009 and available at:. http://www.nice.org.uk/Guidance/TA39.
34. Rennard S.I., Glover E.D., Leischow S., Daughton D.M., Glover P.N., Muramoto M., et al. Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial. Nicotine & Tobacco Research 2006, 8(4):555-564.
35. Rose J.E., Behm F.M., Westman E.C. Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy. Exp Clin Psychopharmacol 1998, 6:331-343.
36. Rose J.E., Behm F.M., Westman E.C., Kukovich P. Pre-cessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine & Tobacco Research 2006, 8:89-101.
37. Rose J.E., Herskovic J.E., Behm F.M., Westman E.C. Pre-cessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment. Poster presented at the Annual Meeting of the Society for Research on Nicotine and Tobacco, Austin, Texas 2007, February.
38. Royal College of Physicians (RCP) Harm reduction in nicotine addiction: helping people who can't quit. A report by the Tobacco Advisory Group of the Royal College of Physicians 2007, RCP, London.
39. Schnoll R., Patterson F., Wileyto P., Heitjan D.F., Shields A., Asch D., et al. Effectiveness of extended-duration transdermal nicotine therapy: A randomized trial. Ann Intern Med 2010, 152(3):144-151.
40. Schuurmans M.M., van Diacon A.H.B.X., Bolliger C.T. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: A randomized controlled trial. Addiction 2004, 99:634-640.
41. Shaneyfelt T., Baum K., Bell D., Feldstein D., Houston T.K., Kaatz S., et al. Instruments for evaluating education in evidence-based practice: A systematic review. JAMA 2006, 296:1116-1127.
42. Shiffman S., Ferguson S.G. Nicotine patch therapy prior to quitting smoking: A meta-analysis. Addiction 2008, 103:557-563.
43. Shiffman S., Ferguson S.G., Gwaltney C.J. Immediate hedonic response to smoking lapses: Relationship to smoking relapse, and effects of nicotine replacement therapy. Psychopharmacology 2006, 184:608-618.
44. Shiffman S., Ferguson S.G., Rohay J., Gitchell J.G. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: Relationship with use and compliance. Addiction 2008, 103:1371-1378.
45. Shiffman S., Ferguson S.G., Strahs K.R. Quitting by gradual smoking reduction using nicotine gum: A randomized controlled trial. Am J Prev Med 2009, 36(2):96-104.
46. Shiffman S., Hughes J.R., Di Marino M.E., Sweeney C.T. Patterns of over-the-counter nicotine gum use: Persistent use and concurrent smoking. Addiction 2003, 98(12):1747-1753.
47. Shiffman S., Hughes J.R., Pillitteri J.L., Burton S.L. Persistent use of nicotine replacement therapy: An analysis of actual purchase patterns in a population based sample. Tobacco Control 2003, 12(3):310-316.
48. Shiffman S., Scharf D.M., Shadel W.G., Gwaltney C.J., Dang Q., Paton S.M., et al. Analyzing milestones in smoking cessation: An illustration from a randomized trial of high dose nicotine patch. Journal of Consulting and Clinical Psychology 2006, 74(2):276-285.
49. Stead L.F., Perera R., Bullen C., Mant D., Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD000146. 10.1002/14651858.CD000146.pub3.
50. Steinberg M.B., Foulds J., Richardson D.L., Burke M.V., Shah P. Pharmacotherapy and smoking cessation at a tobacco dependence clinic. Preventive Medicine 2006, 42:114-119.
51. Sweeney C.T., Fant R.V., Fagerström K.O., McGovern J.F., Henningfield J.E. Combination nicotine replacement therapy for smoking cessation: Rationale, efficacy and tolerability. CNS Drugs 2001, 15(6):453-467.
52. U.S.Department of Health, Human Services (USDHHS) The Health Benefits of Smoking Cessation: A Report of the Surgeon General 1990, U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Rockville, MD.
53. Wennike P., Danielsson T., Landfeldt B., Westin Å., Tønnesen P. Smoking reduction promotes smoking cessation: Results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction 2003, 98:1395-1402.
54. West R. Addressing regulatory barriers to licensing nicotine products for smoking reduction. Addiction 2000, 95(Suppl 1):S29-S34.
55. West R., Hajek P., Foulds J., Nilsson F., May S., Meadows A. A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology (Berl) 2000, 149(3):198-202.
56. West R., McNeill A., Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000, 55(12):987-999.
57. Wileyto E.P., Patterson F., Niaura R., Epstein L.H., Brown R.A., Audrain-McGovern J., et al. Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. Nicotine & Tobacco Research 2005, 7(2):257-268.
58. World Health Organization Europe (WHO/Europe) Report of the second WHO European meeting on evidence-based treatment of tobacco dependence 2000, Partnership to Reduce Tobacco Dependence, Copenhagen, Accessed on 2 April 2009 and available at. http://www.euro.who.int/document/e74765.pdf.
59. Zevin S., Jacob P., Benowitz N.L. Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clinical Pharmacology and Therapeutics 1998, 64(1):87-95.